HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

visilizumab

a humanized non-FcR-binding anti-CD3 antibody for treatment of steroid-refractory acute graft-versus-host disease
Also Known As:
HuM291; Nuvion; SMART anti-CD3
Networked: 21 relevant articles (6 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Targan, Stephan R: 3 articles (11/2010 - 04/2009)
2. Baumgart, Daniel C: 3 articles (11/2010 - 04/2009)
3. Mayer, Lloyd: 3 articles (11/2010 - 11/2007)
4. Sandborn, William J: 3 articles (11/2010 - 04/2009)
5. Lowder, James N: 3 articles (11/2010 - 04/2009)
6. Van Assche, Gert: 2 articles (11/2010 - 11/2007)
7. Plevy, Scott: 2 articles (11/2010 - 11/2007)
8. Frankel, Matthew: 2 articles (11/2010 - 11/2007)
9. Frankel, Matthew B: 2 articles (04/2010 - 04/2009)
10. Mahadevan, Uma: 2 articles (04/2010 - 11/2007)

Related Diseases

1. Ulcerative Colitis
2. Graft vs Host Disease (Graft-Versus-Host Disease)
3. Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
4. Pyoderma Gangrenosum
5. Lymphopenia (Lymphocytopenia)

Related Drugs and Biologics

1. visilizumab
2. infliximab (Remicade)
3. Fibroblast Growth Factor 7
4. Sodium
5. Mesylates (Mesylate)
6. Insulin (Novolin)
7. vernakalant
8. bevacizumab
9. acetyl- 2- naphthylalanyl- 3- chlorophenylalanyl- 1- oxohexadecyl- seryl- 4- aminophenylalanyl(hydroorotyl)- 4- aminophenylalanyl(carbamoyl)- leucyl- ILys- prolyl- alaninamide
10. gefitinib (Iressa)

Related Therapies and Procedures

1. Biological Therapy
2. Nebulizers and Vaporizers (Inhaler)
3. Blood Component Removal (Apheresis)